In a similar HCC model, Zhang et al. identified that through its effects on the miR-374b/hnRNPA1/PKM2 axis, miR-374b overexpression antagonized glycolysis, resulting in sorafenib treatment re-sensitization. Here, PKM is linked to hepatocellular carcinoma.